Download pdf - Pcu 101 polymeric systems

Transcript
Page 1: Pcu 101 polymeric systems

Admire Dube, B. Pharm.(Hons)., M. Pharm., PhD

[email protected]

Office A62

Physical Pharmacy (PCU101)

Page 2: Pcu 101 polymeric systems

2. Polymeric Systems

2

Page 3: Pcu 101 polymeric systems

Reference Text

• Physicochemical principles of pharmacy – Florence, A.T and Attwood, D.

Other useful textbooks:

• Pharmaceutics: the science of dosage form design-Aulton, M.E (Ed).

• Martin’s physical pharmacy and pharmaceutical sciences. Physical Chemical and Biopharmaceutical Principles –Sinko, P.J and Singh, Y (Ed).

3

Page 4: Pcu 101 polymeric systems

Learning objectives

• State the properties of polymers and explain their use in pharmaceutical preparations

4

Page 5: Pcu 101 polymeric systems

Polymers

• Definition:

• A substance of high molecular weight made up of repeating units (monomers).– Short chains with few monomers (oligomers)

– Their size, 3D shape, asymmetry and chemical reactivity give polymers unique properties

• Polymer chains can be linear or branched. Or separate linear and branched chains can be joined by cross-linkers.

• Homo-polymers and co-polymers

• Sources: naturally occurring and synthetic

5

Page 6: Pcu 101 polymeric systems

Polymers

6

Page 7: Pcu 101 polymeric systems

Polymers

7

Page 8: Pcu 101 polymeric systems

Polymers

8

Page 9: Pcu 101 polymeric systems

Polymers

9

Page 10: Pcu 101 polymeric systems

Polymers

• Read and know structures, properties and uses of common polymers used in pharmaceutics, e.g.

• Chitosan, dextran, the cellulose derivatives, alginate, gum tragacanth, acacia, carbopol, pectin, polyvinyl alcohol.

10

Page 11: Pcu 101 polymeric systems

Polymers

• Polymers exist with a range of molecular weights. This is termed polydispersity. E.g. for Chitosan, molecular weight 50-190 000 Daltons

• Calculate number average molecular weight or weight average molecular weight:

Degree of polydispersity = 11

Page 12: Pcu 101 polymeric systems

Polymers (mixtures)

12

Representative polymer-polymer phase behaviour with different molecular architectures. Microphase separation (a) results when thermodynamically incompatible linear homopolymers are mixed. The covalent bond between blocks in a diblockcopolymer leads to microphase segregation (c). A mixed architecture of linear homopolymers and the corresponding diblock copolymer produces a surfactant-like stabilized intermediate-scale phase separation (b).

Page 13: Pcu 101 polymeric systems

Polymers (solubility)

• Rate of solution of a water soluble polymer depends on its Mw. The higher the Mw, the lower the solubility.

• Greater degree of crystallinity, lower solubility.

• Solubility of polymers affects viscosity of solutions– Water-soluble polymers have an ability to increase the viscosity of

solvents at low concentrations, to swell or change shape in solution, and to adsorb at surfaces.

• Therefore slow rate of penetration of solvents (dissolution).

• Use of polymers for controlled drug release

• Use of polymers as suspending agents in formulations (viscosity adjusting agents to prevent fast settling of drug particles in suspensions)

13

Page 14: Pcu 101 polymeric systems

Polymers (solubility)

• Insoluble polymers or polymers with a low rate of solution are used to form thin films, as film-coating materials, surgical dressings or membranes for dialysis or filtration; or to form matrices for enveloping drugs to control their release properties

14

Page 15: Pcu 101 polymeric systems

Polymers (viscosity)

• Viscosity of macromolecules in solution (relative viscosity)

• extrapolate to zero concentration = intrinsic viscosity

• Viscosity changes with shape, solvent binding and ionization. 15

Page 16: Pcu 101 polymeric systems

Polymers (viscosity)

16

Page 17: Pcu 101 polymeric systems

Polymers (gels)

• Viscous cross-linked systems of polymers (in solution) are called gels.• A gel is a polymer–solvent system containing a 3D network of quite

stable bonds which are almost unaffected by thermal motion.• Polymer is cross-linked, solution cannot occur and the polymer will

only swell by imbibition of liquid to form a gel.• Swelling decreases as the degree of crosslinking increases.• 3D network of stable bonds (unaffected by thermal motion)• Critical concentration of gelation is required.• Features of a gel:

– increase in viscosity above the gel point– the appearance of a rubber-like elasticity,– at higher polymer concentrations, a yield point stress

• Types of gels– Type I (irreversible systems with 3D network formed by covalent bonds)– Type II (heat reversible. Intermolecular bonds such as hydrogen bonds)

17

Page 18: Pcu 101 polymeric systems

Polymers (heterogels)

• Use of block co-polymers (AAA-BBB-AAA-BBB)

• Place polymer in solution in which only one of the co-polymers is soluble (e.g. A is water soluble, B water insoluble)

• Produce a heterogel (drug delivery system)

• Poly(oxyethylene)–poly(oxypropylene)–poly(oxyethylene) block copolymers, known commercially as Pluronic or poloxamer surfactants, Formation of micelles.

18

Page 19: Pcu 101 polymeric systems

Syneresis

• Term used to describe separation of fluid from a swollen gel

• A form of instability in aqueous and non-aqueous gels

• Occurs as a result of elastic contraction of the polymeric molecules

– in the swelling process during gel formation, the macromolecules involved become stretched and the elastic forces increase as swelling proceeds. At equilibrium, the restoring force of the macromolecules is balanced by the swelling forces, determined by the osmotic pressure. If the osmotic pressure decreases, for example on cooling, water may be squeezed out of the gel.

19

Page 20: Pcu 101 polymeric systems

Polymers (complexes)

20

• Such macromolecular reactions are highly selective and strongly dependent on molecular size and conformation

• Can also occur in formulations and biological systems (hyaluronic acids and proteoglycans in the intracellular matrix in cartilage)

Page 21: Pcu 101 polymeric systems

Polymers (interactions with ions)

• Ions can bind to polymers inducing gelation

• For example calcium and other multivalent cations can bind to alginate inducing gel formation

• Can be exploited in manufacture of controlled release systems

• Can also have dietary significance. Dietary fibre from plants binds calcium in proportion to its uronic acid content. This binding by the non-cellulosic fraction of fibre reduces the availability of calcium for small-intestinal absorption.

21

Page 22: Pcu 101 polymeric systems

Polymers (interactions with solvents)

22

• Interact in a more complex fashion than small molecules/solutes

• Generally have no saturation solubility (usually dissolves completely or is only swollen by a given liquid)

• Swelling dependent on cross-linking of polymer.

• Swelling decreases as degree of cross-linking increases

• Swelling is also function of the solubility parameter of the solvent.

• If polymer is ionic swelling dependent on ionic strength of solution.

• Increasing ionic strength decreases repulsion between between chains and allows the polymer to shrink.

Page 23: Pcu 101 polymeric systems

Polymers (interactions with solvents)

23

Page 24: Pcu 101 polymeric systems

Polymers

• Characteristics important in defining polymers for formulation

– Glass transition temperature, Tg

– Tensile strength

– Diffusion coefficient

– Hardness (crystallinity)

– Solubility

• Crystallinity defines several features of polymers: rigidity, fluidity, the resistance to diffusion of small molecules in the polymer, and degradation.

• In hydrogels Tg can be measured and is a measure of polymer structure, crosslinking density, solvent content and polymer–solvent

• interactions

24

Page 25: Pcu 101 polymeric systems

Polymers (applications)

• Suspending agents in formulation of suspensions, e.gcarboxypolymethylene (carbopol)

• Film coating of (tablets/granules) e.g. shellac, zein, glycerylstearates, cellulose acetate phthalate

• Drug delivery systems (hydrogels, nanoparticles /micellarstructures), e.g. chitosan, alginate, poly(lactic)glycolic acid– Oral, transdermal, intravenous, implants

25